Therapeutic method for selectively treating terminal deoxynucleotidyl transferase-positive neoplastic leukemias and lymphomas
First Claim
Patent Images
1. A therapeutic method for treating terminal deoxynucleotidyl transferase-positive leukemias and lymphomas in-situ comprising the step of:
- administering a therapeutic composition to the terminal deoxynucleotidyl transferase-positive cells in-situ, said therapeutic composition comprising a nitrogeneous heterocyclic base selected from the group consisting of purines and purines derivatives, and a dideoxy-pentose monosaccharide moiety.
1 Assignment
0 Petitions
Accused Products
Abstract
A therapeutic method for specifically treating terminal deoxynucleotidyl transferase-positive neoplastic disease within living subjects is provided which is uniquely effective and selective. The therapeutic method comprises administering an effective concentration of a therapeutic composition to the subject, the therapeutic composition comprising a nitrogenous heterocyclic base selected from the group consisting of purines and purine derivatives and pyrimidines and pyrimidine derivatives; and a dideoxy-pentose monosaccharide moiety.
-
Citations
5 Claims
-
1. A therapeutic method for treating terminal deoxynucleotidyl transferase-positive leukemias and lymphomas in-situ comprising the step of:
administering a therapeutic composition to the terminal deoxynucleotidyl transferase-positive cells in-situ, said therapeutic composition comprising a nitrogeneous heterocyclic base selected from the group consisting of purines and purines derivatives, and a dideoxy-pentose monosaccharide moiety. - View Dependent Claims (3, 4, 5)
-
2. A therapeutic method for treating terminal deoxynucleotidyl transferase-positive leukemias and lymphomas in-site comprising the step of:
administering a therapeutic composition to the terminal deoxynucleotidyl transferase-positive cells in-situ, said therapeutic composition comprising a nitrogeneous heterocyclic base selected from the group consisting of pyrimidines and pyrimidine derivatives, and a dideoxy-pentose monosaccharide moiety.
Specification